Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Conference attendance

1 Mar 2018 07:00

RNS Number : 3044G
Collagen Solutions PLC
01 March 2018
 

 

1 March 2018

Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference &

Exhibit at American Academy of Orthopaedic Surgeons Conference

Dates: 6-9 March 2018

 

 

Collagen Solutions Plc (AIM: COS), (the "Company"), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine, including orthopaedic, dental, wound care, and cardiovascular applications, confirms two forthcoming conferences it will be attending in New Orleans, Louisiana, USA, between 6-9 March 2018.

· Jamal Rushdy, CEO, to present at the Canaccord Genuity Musculoskeletal Conference (6 March)· Company to Exhibit at the American Academy of Orthopaedic Surgeons "AAOS" Annual Conference (7-9 March)

 

AAOS is the world's largest and most prestigious annual orthopaedic meeting so attending this conference and presenting at the accompanying Canaccord Genuity Musculoskeletal Conference provides access to an extremely wide range of investors and manufacturers in areas of spine, trauma/extremities, foot and ankle, and sports medicine.

 

Commenting on the conferences, Jamal Rushdy, CEO said: "We are pleased to have the opportunity to present at the Canaccord Genuity Musculoskeletal Conference, where we will highlight our recently announced positive 8-year follow-on data from ChondroMimetic® demonstrating durable cartilage regeneration in keyhole knee surgery. We are also excited to be a first-time exhibitor at AAOS and to showcase our OEM capabilities and propriety device licensing opportunities to investors and industry partners. These meetings provide the opportunity to actively engage with orthopaedic companies on a global scale. We will also be providing hands-on demonstrations of prototypes for our Bone Graft Substitute, ChondroMimetic® Cartilage Repair Scaffold, and Fibrillar Collagen development programmes."

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

The American Academy of Orthopedic Surgeons (AAOS)

AAOS is an orthopedic organisation. Founded at Northwestern University in 1933, as of 2015 AAOS had grown to include about 39,000 members. The group provides education and practice management services for orthopedic surgeons and allied health professionals. The AAOS also lobbies and works on public education. The AAOS describes itself as "the world's largest medical association of musculoskeletal specialists.

For more information go to: www.aaos.org

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZMGZZNRFGRZM
Date   Source Headline
27th Aug 20202:30 pmRNSRecommended Cash Offer for Collagen Solutions plc
19th Aug 20207:42 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 20207:48 amRNSForm 8.5 (EPT/NON-RI)
17th Aug 202012:06 pmRNSRule 2.9 Announcement
13th Aug 20201:35 pmGNWForm 8.3 - Collagen Solutions Plc
13th Aug 20209:28 amRNSForm 8.5 (EPT/NON-RI)
12th Aug 20207:00 amRNSAllotment of shares and total voting rights
10th Aug 20208:04 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20208:33 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 202010:17 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202010:49 amRNSForm 8.3 - Collagen Solutions PLC
31st Jul 20207:00 amRNSFinal Results
23rd Jul 20208:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 20207:41 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:54 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:00 amRNSTrading update
16th Jul 202010:51 amRNSForm 8.5 (EPT/NON-RI)
10th Jul 202011:37 amRNSForm 8.3 - Collagen Solutions
10th Jul 202011:15 amRNSAdditional Government Backed Loan Received
10th Jul 20209:30 amRNSForm 8.5 (EPT/NON-RI)
9th Jul 20209:34 amRNSForm 8.3 - Collagen Solutions
7th Jul 20207:00 amRNSCollagen supply agreement with NovaBone Products
6th Jul 20207:00 amRNSRealignment of Bond Repayments
1st Jul 20209:29 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 20208:27 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 202012:07 pmRNSForm 8.5 (EPT/NON-RI)
23rd Jun 202011:04 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 202010:04 amRNSForm 8.5 (EPT/NON-RI)
17th Jun 20209:23 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 202010:06 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20207:00 amRNSTrading Update and Accounts Filing Extension
8th Jun 20208:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 20209:14 amRNSForm 8.5 (EPT/NON-RI)
2nd Jun 202011:29 amRNSForm 8.5 (EPT/NON-RI)
29th May 20208:30 amRNSForm 8.5 (EPT/NON-RI)
21st May 20208:54 amRNSForm 8.5 (EPT/NON-RI)
20th May 20208:55 amRNSForm 8.5 (EPT/NON-RI)
20th May 20207:00 amRNSGovernment Backed Loan and Grant Funding Received
19th May 20204:40 pmRNSSecond Price Monitoring Extn
19th May 20204:35 pmRNSPrice Monitoring Extension
19th May 20202:06 pmRNSSecond Price Monitoring Extn
19th May 20202:00 pmRNSPrice Monitoring Extension
19th May 202011:05 amRNSSecond Price Monitoring Extn
19th May 202011:00 amRNSPrice Monitoring Extension
19th May 20208:38 amRNSForm 8.5 (EPT/NON-RI)
18th May 20207:00 amRNSStrategic Review and Formal Sale Process Update
11th May 20201:11 pmGNWForm 8.3 - Collagen Solutions Plc
4th May 20208:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20204:10 pmRNSForm 8.3 - Collagen Solutions plc
30th Apr 20204:02 pmRNSForm 8.3 - Collagen Solutions plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.